For example, as demonstrated by Liu et al., the treatment of lung cancer cells with WZB117 did not only result in decreased levels of GLUT1 protein but also in a decline in the concentration of intracellular ATP and glycolytic enzymes (112). The gene discussed is SLC2A1; the disease is lung carcinoma.